Apple Q3 Earnings Beat as Record iPhone Sales Offset Services, China Weakness 
Toyota First-Half Global Sales and Production Decline on Weak China Demand, RAV4 Transition 
Qualcomm Stock Falls as Weak Q4 Forecast, Apple Revenue Decline Overshadow AI Data Center Growth 
Roblox Stock Drops 16% as Q3 Bookings Forecast Misses Expectations 
Meta Stock Drops After Earnings Miss as AI Spending and Legal Costs Weigh on Profit 
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline 
Microsoft Stock Jumps as Azure Growth, AI Revenue Beat Expectations 
Sony Eyes $1.3 Billion Tamron Acquisition as Lens Maker Reviews Offer 
Robinhood Q2 Earnings Beat Estimates, But HOOD Stock Falls as Investors Question Profit Quality 
Russia Charges Telegram Founder Pavel Durov With Facilitating Terrorism, Seeks International Arrest 
Samsung Q2 Profit Surges on AI Memory Chip Demand, Forecasts Strong Second Half 
Meta-backed research finds exposure to ‘untrustworthy’ social media is rare. The fine print is less reassuring 
Chipotle Q2 Earnings Beat Expectations as Sales Growth Drives Higher 2026 Outlook 
Colgate-Palmolive Reaffirms 2026 Sales Outlook Despite Weak North America Demand 
Holcim Raises 2026 Outlook After Strong Q2 Earnings Beat 
World game at war: why some European nations have threatened a World Cup boycott 
Rio Tinto Stock Jumps as Strong Earnings, Higher Dividend and AI Metal Demand Boost Outlook 
IRVINE, Calif., May 03, 2018 -- Evolus, Inc. (NASDAQ:EOLS) (“Evolus”), a lifestyle aesthetics company focused on delivering advanced aesthetic procedures and treatments to physicians and consumers, today announced that Murthy Simhambhatla, President and Chief Executive Officer is scheduled to present at the Bank of America Merrill Lynch 2018 Health Care Conference in Las Vegas, NV.
Event: Bank of America Merrill Lynch 2018 Health Care Conference
Date: Thursday, May 17, 2018
Time: 10:00 a.m. PT
Location: The Encore, Las Vegas, NV
An audio webcast of the Company’s presentation will be available on the investor relations section of Evolus’ website at www.Evolus.com. A replay of the webcast will be available for 90 days after the date of the presentation.
The Company will also be hosting one-on-one investor meetings at the conference on Wednesday, May 16. If interested in meeting with management, please reach out to Brian Johnston at [email protected] or your Bank of America Merrill Lynch contact.
About Evolus, Inc.
Evolus is a medical aesthetics company dedicated to bringing advanced aesthetic procedures and treatments to physicians and consumers. Evolus focuses on the self-pay aesthetic market and its lead product candidate DWP-450 (prabotulinumtoxinA), an injectable 900 kDa purified botulinum toxin type A complex.
Evolus Contacts:
Media:
Kirsten Thomas, The Ruth Group
Tel: +1-508-280-6592
Email: [email protected]
Investor Contact:
Brian Johnston, The Ruth Group
Tel: +1 646-536-7028
Email: [email protected]
